Dáil Éireann Debate, Tuesday - 21 March 2017
801. Deputy Louise O'Reilly asked the Minister for Health the status of negotiations between his Department and pharmaceutical companies to secure an agreed price for the drug Sativex (details supplied). [13166/17]
View answerThe HSE has statutory responsibility for decisions on the reimbursement of approved products in Ireland and suppliers of such products must apply to the HSE for reimbursement approval.
I am advised that, following receipt of an application from the supplier for the inclusion of Sativex on the High Tech Scheme, the HSE assessed the medicine in line with their statutory responsibility. The HSE issued the manufacturers with notice of its intention not to reimburse. It is open to the supplier to make a new application for this product, in the context of the previous findings.
